M. Al-Hayali

Codrug Approach for the Potential Treatment of EML4-ALK Positive Lung Cancer.

T. Bradshaw, P. Gershkovich, Michael J. Stocks, 2019, ACS medicinal chemistry letters.

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

K. C. Morris, Michele R. Shaw, Mohammed Salah Ibrahim, 2023, The Lancet.

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

K. C. Morris, Mohammed Salah Ibrahim, K. Y. Wong, 2022, medRxiv.

Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system

Min Gi Kim, P. Fischer, B. Shin, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Lipophilic activated ester prodrug approach for drug delivery to the intestinal 1 lymphatic system 2 3

Fadi, Min Gi Kim, P. Fischer, 2018 .

Discovery of a highly active anticancer analogue of cardamonin that acts as an inducer of caspase-dependent apoptosis and modulator of the mTOR pathway.

T. Bradshaw, C. Wiart, S. Chow, 2018, Fitoterapia.

A Codrug Approach for the Potential Treatment of EML4-ALK Positive Lung Cancer .

P. Gershkovich, Michael J. Stocks, Aimie E. Garces, 2019 .

Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity

T. Bradshaw, H. Collins, Michael J. Stocks, 2021, Molecules.